Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01508117
Title Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Cincinnati
Indications

glioblastoma

Therapies

Axitinib

Age Groups: senior
Covered Countries USA


No variant requirements are available.